NYSE:BCSFBain Capital Specialty Finance Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Bain Capital Specialty Finance Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $10.17 +0.10 (+0.99 %) (As of 08/3/2020 04:00 PM ET) Add Compare Share Today's Range$10.05Now: $10.17▼$10.4750-Day Range$9.48MA: $10.85▼$12.4352-Week Range$7.11Now: $10.17▼$20.35Volume172,683 shsAverage Volume333,887 shsMarket Capitalization$525.28 millionP/E RatioN/ADividend Yield16.29%Beta1.5 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Bain Capital Specialty Finance, Inc. operates as a business development company (BDC) specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.Read More Beat the Market (BTM) Rank™ 2.0 Analyst's Opinion Consensus RatingBain Capital Specialty Finance has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 6 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.14, Bain Capital Specialty Finance has a potential upside of 19.4% from its current price of $10.17.Amount of Analyst CoverageBain Capital Specialty Finance has only been the subject of 3 research reports in the past 90 days. Previous Next 1.8 Community Rank Outperform VotesBain Capital Specialty Finance has received 40 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBain Capital Specialty Finance has received 72 “underperform” votes. (Add your “underperform” vote.)Community SentimentBain Capital Specialty Finance has received 64.29% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Bain Capital Specialty Finance and other stocks. Vote “Outperform” if you believe BCSF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BCSF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipBain Capital Specialty Finance is a leading dividend payer. It pays a dividend yield of 16.29%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthBain Capital Specialty Finance has only been increasing its dividend for 1 years.Dividend CoverageThe dividend payout ratio of Bain Capital Specialty Finance is 100.00%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on EPS estimates, Bain Capital Specialty Finance will have a dividend payout ratio of 120.59% in the coming year. This indicates that Bain Capital Specialty Finance may not be able to sustain their current dividend. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Bain Capital Specialty Finance insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.43% of the stock of Bain Capital Specialty Finance is held by insiders.Percentage Held by Institutions52.03% of the stock of Bain Capital Specialty Finance is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Bain Capital Specialty Finance are expected to decrease by -7.48% in the coming year, from $1.47 to $1.36 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Bain Capital Specialty Finance is -11.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bain Capital Specialty Finance is -11.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBain Capital Specialty Finance has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.0Community Rank: 1.8Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.42 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Holding & other investment offices Sub-IndustryN/A SectorFinance Current SymbolNYSE:BCSF Previous Symbol CUSIPN/A CIKN/A Webwww.baincapital.com Phone617-516-2000Debt Debt-to-Equity Ratio1.85 Current Ratio2.11 Quick Ratio2.11Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio6.92 P/E GrowthN/A Sales & Book Value Annual Sales$197.95 million Price / Sales2.65 Cash Flow$1.60 per share Price / Cash Flow6.35 Book Value$19.72 per share Price / Book0.52Profitability EPS (Most Recent Fiscal Year)$1.64 Net Income$98.08 million Net Margins-21.80% Return on Equity8.72% Return on Assets3.26%Miscellaneous EmployeesN/A Outstanding Shares51,650,000Market Cap$525.28 million Next Earnings Date8/5/2020 (Confirmed) OptionableNot Optionable $10.17 +0.10 (+0.99 %) (As of 08/3/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive BCSF News and Ratings via Email Sign-up to receive the latest news and ratings for BCSF and its competitors with MarketBeat's FREE daily newsletter. Bain Capital Specialty Finance (NYSE:BCSF) Frequently Asked Questions How has Bain Capital Specialty Finance's stock been impacted by COVID-19 (Coronavirus)? Bain Capital Specialty Finance's stock was trading at $16.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BCSF stock has decreased by 39.6% and is now trading at $10.17. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Bain Capital Specialty Finance? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last year. There are currently 1 sell rating, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Bain Capital Specialty Finance. When is Bain Capital Specialty Finance's next earnings date? Bain Capital Specialty Finance is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Bain Capital Specialty Finance. How can I listen to Bain Capital Specialty Finance's earnings call? Bain Capital Specialty Finance will be holding an earnings conference call on Wednesday, August 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available. How were Bain Capital Specialty Finance's earnings last quarter? Bain Capital Specialty Finance Inc (NYSE:BCSF) released its earnings results on Monday, May, 4th. The company reported $0.44 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.41 by $0.03. The business earned $51.50 million during the quarter, compared to analyst estimates of $54.41 million. Bain Capital Specialty Finance had a positive return on equity of 8.72% and a negative net margin of 21.80%. View Bain Capital Specialty Finance's earnings history. How often does Bain Capital Specialty Finance pay dividends? What is the dividend yield for Bain Capital Specialty Finance? Bain Capital Specialty Finance announced a quarterly dividend on Monday, May 4th. Investors of record on Tuesday, June 30th will be paid a dividend of $0.41 per share on Thursday, July 30th. This represents a $1.64 dividend on an annualized basis and a yield of 16.13%. The ex-dividend date of this dividend is Monday, June 29th. View Bain Capital Specialty Finance's dividend history. What price target have analysts set for BCSF? 8 equities research analysts have issued 1 year price objectives for Bain Capital Specialty Finance's stock. Their forecasts range from $7.50 to $19.50. On average, they anticipate Bain Capital Specialty Finance's share price to reach $12.14 in the next twelve months. This suggests a possible upside of 19.4% from the stock's current price. View analysts' price targets for Bain Capital Specialty Finance. Has Bain Capital Specialty Finance been receiving favorable news coverage? Media headlines about BCSF stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Bain Capital Specialty Finance earned a media sentiment score of 1.6 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Bain Capital Specialty Finance. Who are some of Bain Capital Specialty Finance's key competitors? Some companies that are related to Bain Capital Specialty Finance include Verra Mobility (VRRM), AdaptHealth (AHCO), HL Acquisitions (LPRO), GS ACQUISITION /SH CL A (GSAH), Flying Eagle Acquisition (FEAC), Collier Creek (CCH), SOCIAL CAP HEDO/SH CL A (IPOB), Social Capital Hedosophia Holdings Corp. III (IPOC), HAYMAKER ACQUIS/SH CL A (HYAC), FORTRESS VALUE /SH (FVAC), Pure Acquisition (PACQ), Leisure Acquisition (NEBU), Global Cord Blood (CO), CF Finance Acquisition (CFFA) and Gores Holdings III (GRSH). View all competitors. What other stocks do shareholders of Bain Capital Specialty Finance own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Verizon Communications (VZ), Honeywell International (HON), CVS Health (CVS), Home Depot (HD), Altria Group (MO), Pfizer (PFE), AT&T (T), Alibaba Group (BABA), Cisco Systems (CSCO) and Walt Disney (DIS). Who are Bain Capital Specialty Finance's key executives? Bain Capital Specialty Finance's management team includes the following people: Mr. Michael Alexander Ewald, Pres, CEO & Director (Age 45)Ms. Sally Fassler Dornaus CPA, CPA, Chief Financial Officer (Age 44)Mr. Derek Kirby, Investor ContactMr. James Goldman, Chief Compliance Officer (Age 42)Mr. James S. Athanasoulas, VP & Treasurer (Age 45) When did Bain Capital Specialty Finance IPO? (BCSF) raised $156 million in an initial public offering on Thursday, November 15th 2018. The company issued 7,500,000 shares at a price of $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities served as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers. What is Bain Capital Specialty Finance's stock symbol? Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF." Who are Bain Capital Specialty Finance's major shareholders? Bain Capital Specialty Finance's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include UBS Group AG (3.31%), Starr International Co. Inc. (1.43%), Sumitomo Mitsui Trust Holdings Inc. (0.88%), C.V. Starr & Co. Inc. Trust (0.74%), Raymond James Financial Services Advisors Inc. (0.20%) and Mount Yale Investment Advisors LLC (0.20%). Company insiders that own Bain Capital Specialty Finance stock include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle and Thomas A Hough. View institutional ownership trends for Bain Capital Specialty Finance. Which institutional investors are selling Bain Capital Specialty Finance stock? BCSF stock was sold by a variety of institutional investors in the last quarter, including Parallel Advisors LLC, Mission Wealth Management LP, Texas Yale Capital Corp., FCG Advisors LLC, JNB Advisors LLC, and CFO4Life Group LLC. View insider buying and selling activity for Bain Capital Specialty Finance. Which institutional investors are buying Bain Capital Specialty Finance stock? BCSF stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG, Sumitomo Mitsui Trust Holdings Inc., Mckinley Capital Management LLC Delaware, Mount Yale Investment Advisors LLC, C.V. Starr & Co. Inc. Trust, Starr International Co. Inc., Triad Investment Management, and Koshinski Asset Management Inc.. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, and Thomas A Hough. View insider buying and selling activity for Bain Capital Specialty Finance. How do I buy shares of Bain Capital Specialty Finance? Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Bain Capital Specialty Finance's stock price today? One share of BCSF stock can currently be purchased for approximately $10.17. How big of a company is Bain Capital Specialty Finance? Bain Capital Specialty Finance has a market capitalization of $525.28 million and generates $197.95 million in revenue each year. The company earns $98.08 million in net income (profit) each year or $1.64 on an earnings per share basis. What is Bain Capital Specialty Finance's official website? The official website for Bain Capital Specialty Finance is www.baincapital.com. How can I contact Bain Capital Specialty Finance? Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-516-2000 or via email at [email protected] This page was last updated on 8/3/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
